Published online 18 April 2005. doi:10.1083/jcb.200410041
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 169, Number 2, 331-339
Phosphorylation of p66Shc and forkhead proteins mediates Aß toxicity
Wanli W. Smith1,
Darrell D. Norton1,
Myriam Gorospe1,
Haibing Jiang2,
Shino Nemoto3,
Nikki J. Holbrook5,
Toren Finkel3, and
John W. Kusiak4
1 Molecular Neurobiology Unit, Laboratory of Cellular and Molecular Biology, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
2 Johns Hopkins University School of Medicine, Baltimore MD 21205
3 National Heart, Lung and Blood Institute
4 Molecular and Cellular Neurobiology Program, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892
5 Yale University School of Medicine, New Haven, CT 06520
Correspondence to Wanli W. Smith: wsmith60{at}jhmi.edu
Excessive accumulation of amyloid ß-peptide (Aß) plays an early and critical role in synapse and neuronal loss in Alzheimer's Disease (AD). Increased oxidative stress is one of the mechanisms whereby Aß induces neuronal death. Given the lessened susceptibility to oxidative stress exhibited by mice lacking p66Shc, we investigated the role of p66Shc in Aß toxicity. Treatment of cells and primary neuronal cultures with Aß caused apoptotic death and induced p66Shc phosphorylation at Ser36. Ectopic expression of a dominant-negative SEK1 mutant or chemical JNK inhibition reduced Aß-induced JNK activation and p66Shc phosphorylation (Ser36), suggesting that JNK phosphorylates p66Shc. Aß induced the phosphorylation and hence inactivation of forkhead transcription factors in a p66Shc-dependent manner. Ectopic expression of p66ShcS36A or antioxidant treatment protected cells against Aß-induced death and reduced forkhead phosphorylation, suggesting that p66Shc phosphorylation critically influences the redox regulation of forkhead proteins and underlies Aß toxicity. These findings underscore the potential usefulness of JNK, p66Shc, and forkhead proteins as therapeutic targets for AD.
W.W. Smith's present address is Dept. of Psychiatry, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Abbreviations used in this paper: Aß, amyloid ß-peptide; AD, Alzheimer's Disease; DCF, 2',7'-dichlorofluorescein; DCFDA, DCF diacetate; DHR, dihydrorhodamine; DIV, day in vitro; FKH, forkhead transcription factor; HE, hydroethidine; MnSOD, manganese superoxide dismutase; NAC, N-acetylcysteine; PP2A1, serine/threonine protein phosphatase 2A1; ROS, reactive oxygen species.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Xi, G., Shen, X., Clemmons, D. R.
(2008). p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane Recruitment. Mol. Endocrinol.
22: 2162-2175
[Abstract]
[Full Text]
-
Petti, L. M., Ricciardi, E. C., Page, H. J., Porter, K. A.
(2008). Transforming signals resulting from sustained activation of the PDGF{beta} receptor in mortal human fibroblasts. J. Cell Sci.
121: 1172-1182
[Abstract]
[Full Text]
-
Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M., Ross, C. A.
(2005). Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. USA
102: 18676-18681
[Abstract]
[Full Text]
-
Smith, W. W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., Dawson, V. L., Dawson, T. M., Ross, C. A.
(2005). Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet
14: 3801-3811
[Abstract]
[Full Text]
-
Leslie, M.
(2005). Shields Down. Sci Aging Knowl Environ
2005: nf32-nf32
[Abstract]
[Full Text]